Literature DB >> 3366248

Hydrophobic 3.7 kDa surfactant polypeptide: structural characterization of the human and bovine forms.

J Johansson1, H Jörnvall, A Eklund, N Christensen, B Robertson, T Curstedt.   

Abstract

The human and bovine forms of the hydrophobic 3.7 kDa surfactant polypeptide have been structurally analyzed. The polypeptide is essentially inert to enzymatic proteolysis, and methods for analysis include peptide handling in organic solvents and fragment generation by limited acid hydrolysis. The molecule exhibits N-terminal trimming, and the relative abundance of the different starting positions varies both among species and between adult and fetal forms of the surfactant polypeptide. The bovine major form is one residue shorter than the mature 35-residue human molecule. Comparison of the porcine, human and bovine polypeptides reveals a conserved hydrophobic middle/C-terminal segment and a variable hydrophilic N-terminal part.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366248     DOI: 10.1016/0014-5793(88)80386-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

2.  Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups.

Authors:  T Curstedt; J Johansson; P Persson; A Eklund; B Robertson; B Löwenadler; H Jörnvall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.

Authors:  M Palmblad; J Johansson; B Robertson; T Curstedt
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

4.  Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C.

Authors:  J Johansson; G Nilsson; R Strömberg; B Robertson; H Jörnvall; T Curstedt
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

5.  Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.